"Zoetis Plummets on Reports of Pet Arthritis Drug Side Effects"

TL;DR Summary
Zoetis Inc. experienced a significant drop in its stock value following a news report raising safety concerns about the company's arthritis drugs for animals, leading to the biggest intraday decline in 17 months and positioning it as one of the worst performers in the S&P 500 Index on Friday.
Topics:business#arthritis-drugs#business-pharmaceuticals#pet-medications#pharmaceutical-industry#stock-market#zoetis-inc
- Zoetis Sinks Most in 17 Months After Report on Pet Arthritis Drugs Bloomberg
- Zoetis Stock Dives On Report Arthritis Shots Sickened Dogs, Cats Investor's Business Daily
- Animal Health Giant Zoetis Stock Crumbles: Possible Side Effect Of Its Pet Arthritis Pain Drugs Sickened Dogs, Cats Yahoo Finance
- Zoetis falls 8% after report that its arthritis shots may have sickened pets MarketWatch
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
0 min
vs 1 min read
Condensed
6%
52 → 49 words
Want the full story? Read the original article
Read on Bloomberg